PimedBio Joins Institut Pasteur Korea’s ‘Bio Core Facility’ Program

— Establishing a Strategic R&D Base to Secure Global Competitiveness via Government-backed Initiative —

PimedBio, a biopharmaceutical R&D company, is pleased to announce its participation in the induction ceremony for the ‘Bio Core Facility Construction Project’ held at Institut Pasteur Korea (IPK) in Pangyo Techno Valley on February 8.

Supported by the Ministry of Science and ICT (MSIT), the ‘Bio Core Facility’ project is a prestigious national initiative designed to accelerate the growth of promising biotech startups. The program provides a comprehensive support system, including laboratory space, advanced research equipment, R&D funding, and expert business consulting. PimedBio was selected as one of the five innovative companies to join this elite ecosystem following a rigorous evaluation process.

 Through this residency, PimedBio will leverage IPK’s world-class research infrastructure to advance its pipeline:

• Access to Advanced Infrastructure: Shared use of IPK’s core facilities and high-end analytical equipment essential for drug discovery.

• Active Collaborative R&D: Opportunities for joint research with IPK’s expert researchers and access to their extensive global scientific network.

• Accelerated Growth: Strengthening global competitiveness through IPK’s systematic business support and specialized consulting.

•  

 By establishing a presence within the vibrant innovation ecosystem of Pangyo Techno Valley, PimedBio is committed to accelerating the development of its differentiated anti-cancer therapeutics. We will continue to evolve into a globally competitive biotech leader, delivering breakthrough solutions to the healthcare industry.